Allreal Holding AG (0QPD)
London Exchange · UK · prices in GBP · close of 23 Oct 2026
Key indicators
| Last close | GBP 191.60 |
|---|---|
| 52-week range | 185.00 – 238.50 |
| Return, 1 month / 3 months | −2.8% / −10.9% |
| Return, 1 year / 3 years | −0.8% / +35.6% |
| Trend | Below its 200-day average |
| RSI (14) | 54 |
| Volatility (1 year) | 13.9% |
| Worst drawdown (1 year) | -22.1% |
| Average daily value traded | 0.76M GBP |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Allreal Holding is a Swiss real estate company based in Zug that develops and owns property. It builds residential and commercial developments, largely in and around the Zurich area, and keeps a portfolio of investment properties that it rents out to tenants. Its activities span project development, construction and the long-term management of its own buildings, giving it a mix of development income and rental income from offices, retail space and homes.
Allreal Holding AG trades under the code 0QPD on the London Exchange in UK, with its price quoted in pounds sterling (GBP). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Allreal Holding AG (0QPD) trades on the London Exchange in UK. It last closed at GBP 191.60 on 23 October 2026.
Its price-based Market X-Ray is 49 out of 100 (a weak price profile), ranking 2,094 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 0.8% and over the last three months it fell 10.9%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 33 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -9.4% | ||
| From 52-week high | -19.5% | ||
| Momentum | 34 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -10.9% | ||
| 6-month return | -10.9% | ||
| 12-month return, skipping the last month | 2.1% | ||
| Stability (higher is calmer) | 81 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 13.9% | ||
| Worst drawdown, 1 year (smaller is calmer) | -22.1% | ||
| Liquidity | 50 · Fair | Moderate trading activity. | |
| Average daily value traded | 0.76M GBP | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 5 |
Strengths
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
Returns
| 1 week | +2.0% |
|---|---|
| 1 month | −2.8% |
| 3 months | −10.9% |
| 6 months | −10.9% |
| 1 year | −0.8% |
| 3 years | +35.6% |
| 5 years | −2.2% |
Signals
| 50-day / 200-day average | 193.86 / 211.41 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 2.13 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 21 Apr 2026 | GBX 0.0350 |
| 29 Apr 2025 | GBX 0.0350 |
| 23 Apr 2024 | GBX 0.0350 |
| 25 Apr 2023 | GBX 0.0350 |
| 12 Apr 2022 | GBX 0.0350 |
| 20 Apr 2021 | GBX 0.0350 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.